-
-
-
-
-
-
-
Abbott shares dip on soft current-quarter guide; Q1 results in line
-
-
-
-
-
-
-
Abbott Labs (ABT) PT Lowered to $119 at Leerink Partners
-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Abbott Labs (ABT), Highlights Buying Opportunity
-
-
-
-
-
-
-
Here are the October additions to Goldman's 'U.S. Conviction List - Directors' Cut
-
-
-
-
-
-
-
Abbott Reports Second-Quarter 2025 Results
-
-
-
-
-
-
-
Abbott Labs (ABT) PT Raised to $145 at BTIG
-
-
-
-
-
-
-
RBC Capital Assesses U.S. Tariff Impact Across Industries
-
1,203,959 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

